2020
DOI: 10.1002/mnfr.201901166
|View full text |Cite
|
Sign up to set email alerts
|

Consumption of Diet Soda Sweetened with Sucralose and Acesulfame‐Potassium Alters Inflammatory Transcriptome Pathways in Females with Overweight and Obesity

Abstract: Scope Low‐calorie sweetener (LCS) consumption is associated with metabolic disease in observational studies. However, physiologic mechanisms underlying LCS‐induced metabolic impairments in humans are unclear. This study is aimed at identifying molecular pathways in adipose impacted by LCSs. Methods and results Seven females with overweight or obesity, who did not report LCS use, consumed 12 ounces of diet soda containing sucralose and acesulfame‐potassium (Ace‐K) three times daily for 8 weeks. A subcutaneous a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 50 publications
0
15
0
1
Order By: Relevance
“…Our results highlight the need for further in vivo studies, measuring production and accumulation of reactive oxygen species, in a dose-dependent fashion as well as increased fat accumulation, leading to increased insulin resistance and CVD. In fact, our in vivo study [22] indicates that sucralose promotes acute inflammatory response and our in vitro results suggest that rapid and immediate ROS accumulation may be the mechanism. Our results explain adverse associations between NNS consumption and cardiometabolic health reported in epidemiological studies at a cellular level.…”
Section: Discussionmentioning
confidence: 54%
“…Our results highlight the need for further in vivo studies, measuring production and accumulation of reactive oxygen species, in a dose-dependent fashion as well as increased fat accumulation, leading to increased insulin resistance and CVD. In fact, our in vivo study [22] indicates that sucralose promotes acute inflammatory response and our in vitro results suggest that rapid and immediate ROS accumulation may be the mechanism. Our results explain adverse associations between NNS consumption and cardiometabolic health reported in epidemiological studies at a cellular level.…”
Section: Discussionmentioning
confidence: 54%
“…The most pronounced sex-specific differences were those observed for immune-related genes. In humans, while obesity is commonly associated with low-grade chronic inflammation, Ace-K has been shown to dysregulate inflammatory homeostasis in adipose tissue [17], effects of which in our study were more pronounced in females as compared to males. Cxcr3, for example, contributes to T-cell recruitment into adipose tissue in obese mice [53].…”
mentioning
confidence: 40%
“…Treatment of mouse and human precursor cells by Ace-K has been shown to induce adipogenesis, indicating that these compounds influence adipocyte differentiation [16]. In obese human subjects, consumption of diet drinks containing Ace-K leads to a dysregulation in inflammatory pathways within the adipose tissue [17].…”
Section: Introductionmentioning
confidence: 99%
“…The scientific literature is replete with narrative reviews claiming to address mechanisms “…responsible for the development of metabolic syndrome associated with NNS [non-nutrivie sweetener] consumption” [ 5 ] and that “…contribute to the negative metabolic effects of non-nutritive sweeteners…” [ 6 ], “…demonstrating the role of the microbiota in glucose intolerance in response to noncaloric artificial sweeteners…” [ 7 ]. Indeed, it seems that researchers assume that (new) mechanistic evidence of adverse effects will be found even before experiments are run, pre-registering research protocols with titles, such as “Low-calorie Sweeteners Induce Metabolic Dysregulation Via Alterations in Adipose Signaling” (ClinicalTrials.gov Identifier NCT03125356; an uncontrolled trial that, in fact, found no metabolic dysregulation or changes in any higher-level physiological markers or outcomes [ 8 ]).…”
Section: Perspectivementioning
confidence: 99%